GeoVax Reports 2019 Second Quarter Financial Results and Highlights Corporate Development Progress

NEXT STORY
Ziopharm Oncology Announces Publication of Positive Results of Phase 1 Monotherapy Trial of Controlled IL-12 in Patients with Recurrent Glioblastoma in Science Translational Medicine
PREV STORY
Vaccinex Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tesaro to Announce Fourth-Quarter 2016 Financial Results on February 28, 2017

WALTHAM, Mass., Feb. 14, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce its ...

author_avatar
NASDAQ Market News

PAVmed Subsidiary Lucid Diagnostics Launches World-Class Medical Advisory Board and Appoints Chief Medical Officer

author_avatar
NASDAQ Market News

Knight Therapeutics Reports Fourth Quarter and Year End 2019 Results

author_avatar
NASDAQ Market News